{"product_id":"palexia-ir-tab-50mg","title":"Palexia IR Tab 50mg","description":"\u003cdiv class=\"product-description\"\u003e\n\u003ch1\u003ePalexia IR Tablets 50mg – Tapentadol Hydrochloride\u003c\/h1\u003e\n\u003cp\u003e\u003cstrong\u003eActive Ingredient:\u003c\/strong\u003e Tapentadol 50 mg (as tapentadol hydrochloride)\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFormulation:\u003c\/strong\u003e Immediate-Release, film-coated oral tablet\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePalexia IR 50 mg\u003c\/strong\u003e delivers rapid-onset relief for severe, acute pain when alternative analgesics are inadequate. Each tablet contains tapentadol, an opioid agonist with dual mechanisms of action – μ-opioid receptor agonism and noradrenaline re-uptake inhibition – providing effective pain control with a favourable gastrointestinal tolerability profile.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrength:\u003c\/strong\u003e 50mg tapentadol per tablet\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndication:\u003c\/strong\u003e Short-term management of severe acute pain responsive to opioid therapy\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOnset:\u003c\/strong\u003e Rapid absorption; peak plasma levels typically within 1 hour\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosing:\u003c\/strong\u003e Individualised – usually 50–100 mg every 4–6 hours as required, not to exceed 600 mg in 24 hours\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSchedule:\u003c\/strong\u003e Schedule 8 (Controlled Drug) – \u003cem\u003ePrescription Only Medicine\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePack Sizes:\u003c\/strong\u003e Commonly supplied in blister packs of 20 \u0026amp; 60 tablets (check availability)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExcipients:\u003c\/strong\u003e Includes lactose, povidone, and magnesium stearate (full list in CMI\/PI)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store below 25 °C in a dry place; keep out of reach of children\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Grünenthal GmbH \/ Seqirus (Australia) Pty Ltd\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eClinical Considerations:\u003c\/strong\u003e Palexia IR should be reserved for patients where non-opioid and step-two opioid analgesics are insufficient. Monitor for opioid-related adverse effects and signs of misuse. Contra-indicated in severe respiratory depression, acute asthma, or paralytic ileus.\u003c\/p\u003e\n\u003cp class=\"disclaimer\"\u003e\u003cem\u003ePrescription Only Medicine – Authorised prescriber required.\u003c\/em\u003e\u003cbr\u003eAlways read the Product Information before prescribing. This web page is provided for professional reference only and is not a substitute for medical advice. Use strictly as directed.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrder from Medshop\u003c\/strong\u003e – registered healthcare practitioners can source Palexia IR 50 mg quickly and securely through our pharmaceutical supply channel.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Seqirus Australia","offers":[{"title":"Default Title","offer_id":52367866134892,"sku":"PHA17038","price":30.41,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0012\/8440\/7394\/files\/palexia-ir-tab-50mg-seqirus-australia-1218343180.webp?v=1769545999","url":"https:\/\/checkout.medshop.com.au\/products\/palexia-ir-tab-50mg","provider":"Medshop Australia","version":"1.0","type":"link"}